NCT00003593 2013-06-27Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeChildren's Oncology GroupPhase 3 Completed254 enrolled